RALEIGH - Opus Genetics recently announced it would open its third preclinical trial, just a few months after the company formed with a $19 million seed
Ocular gene therapy biotech launches with $19M seed funding biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.
Opus Genetics, launching from Raleigh-based Retinal Degeneration Fund, raises $19M wraltechwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wraltechwire.com Daily Mail and Mail on Sunday newspapers.